Treatment of Obsessive-Compulsive Disorder
Completed · Phase 4 · Has a placebo group
Conditions studied: Obsessive-Compulsive Disorder
In brief
The purpose of this study is to find the best treatment for Tourette's Syndrome (TS)-spectrum obsessive-compulsive disorder (OCD), which includes symptoms of TS, e.g., repeated and involuntary body movements (tics). There are 2 parts to this study: In Part 1, patients are placed into 1 of 2 groups based on type of OCD, determined by medical history and family member interviews. In Part 2, patients are treated with fluvoxamine (FVX) for 8 weeks. If patients do not respond to FVX alone, either haloperidol or an inactive placebo will be added to the FVX regimen; patients will take this drug combination for 4 weeks. Patients will be monitored throughout the trial.
Key facts
- Study ID
- NCT00000373
- Run by
- University of Florida
- People needed
- 74
- Starts
- 1992-09-01
- Expected to finish
- 2003-07-01
- Last updated by the study team
- 2013-11-27
Who can join
Age: 14 and older, up to 70. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Psychiatric Specialty Clinic, Shands Hospital at the University of Florida — Gainesville, Florida, United States
- University of Florida Behavioral Health Mandarin Clinic — Jacksonville, Florida, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.